Replies to post #10952 on NanoLogix Inc (NNLX)

[Rockus]

What kind of back-of-the-napkin calculations did you come up with?


------

If we assume 30m tests annually in the US, and NNLX in use 25% of the time, with licensing income at $1 per test, income would be $7.5m annually.

At a 10x P/E ratio, the company would be valued at $75m, or $0.45 share.

------

If we assume 30m tests annually in the US, and NNLX in use 50% of the time, with licensing income at $2 per test, income would be $30m annually.

At a 15x P/E ratio, the company would be valued at $450m, or $3 a share.

------

If we assume 60m tests annually worldwide, and NNLX in use 75% of the time, with licensing income at $3 per test, income would be $135m annually.

At a 20x P/E ratio, the company would be valued at $2.7b, or $17 a share.

------

all we have to do is wait! lol